JGC
PLX icon

J. Goldman & Co’s Protalix BioTherapeutics PLX Stock Holding History

J. Goldman & Co’s Portfolio PLX Stock Details PLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-12,330
Closed -$25K – 236
2019
Q3 		$25K Sell
12,330
-37,670
-75% -$76.4K ﹤0.01% 158
2019
Q2 		$235K Buy
+50,000
New +$235K 0.02% 154